APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Apyx Medical Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$2.42−0.13 (-5.10%)

Close on Oct 19, 2026

Market cap: $106.12M
P/E (TTM): –
Dividend yield: –

Apyx Medical Corp balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	32	32	44	10	31	42	59	17	11	15	13	5.73	7.92	4.16	4.88	3.83	2.16	2.56
Short-Term Investments	–	–	–	–	–	40	57	62	0	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	32	32	44	10	31	82	115	78	11	15	13	5.73	7.92	4.16	4.88	3.83	2.16	2.56
Receivables	17	15	14	11	13	8.40	7.99	5.08	4.86	4.73	2.93	1.99	1.99	2.87	2.22	2.11	–	–
Inventory	8.60	7.56	9.92	12	6.78	4.05	5.07	5.30	4.27	6.16	5.96	5.73	8.42	7.54	8.18	7.61	–	–
Prepaid Expenses & Other	1.35	1.66	2.76	2.74	1.93	2.80	3.21	1.18	0.43	0.41	0.52	0.80	0.55	0.95	0.71	0.97	–	–
Total Current Assets	58	56	70	43	61	66	77	90	23	27	22	15	20	16	16	15	–	–
Property, Plant & Equipment	2.37	1.99	1.92	6.76	6.58	6.54	6.62	5.79	6.03	6.45	6.81	6.95	7.06	7.23	7.18	7.43	–	–
Gross Property, Plant & Equipment	6.50	5.34	5.04	11	11	11	11	12	12	14	14	13	13	13	12	–	–	–
Accumulated Depreciation	-4.29	-3.99	-3.52	-5.04	-5.32	-4.81	-4.40	-6.36	-5.94	-7.27	-6.87	6.35	5.67	-5.45	-5.00	–	–	–
Land	–	–	–	–	–	–	–	–	–	–	1.60	1.60	1.60	–	–	–	–	–
Buildings & Improvements	–	–	–	–	–	–	–	–	–	–	4.20	3.90	3.87	–	–	–	–	–
Machinery & Equipment	–	–	–	–	–	–	–	–	–	–	3.93	3.98	3.89	–	–	–	–	–
Construction in Progress	0.16	0.64	0.40	0.51	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	4.22	4.70	5.16	0.71	0.12	0.24	0.35	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	0.19	0.19	0.19	0.19	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	0.19	0.07	0.22	0.32	0.43	0.58	0.66	0.75	1.60	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	–	0	0.03	–	3.41	1.80	1.51	1.53	–	–
Other Long-Term Assets	1.75	1.66	1.73	1.22	1.11	0.81	0.39	0.04	0.07	0.10	0.43	0.42	0.67	0.60	0.78	0.71	–	–
Total Assets	67	65	79	52	69	74	85	96	31	35	31	25	33	28	28	28	–	–
Accounts Payable	3.06	2.62	2.71	2.67	2.63	1.51	2.44	1.42	1.58	1.61	1.21	1.55	1.06	0.80	1.09	0.95	–	–
Accrued Expenses	8.21	7.75	9.66	8.93	10	7.28	9.40	5.87	0.21	2.60	2.12	1.60	0.87	0.45	0.35	0.44	–	–
Current Portion of Long-Term Debt	–	–	–	0	–	–	–	0	0.24	0.24	0.24	–	–	–	–	–	–	–
Current Debt	–	–	–	0	–	–	–	0	0.24	0.24	0.24	–	–	–	–	–	–	–
Current Portion of Leases	0.41	0.34	0.35	0.22	0.12	0.13	0.11	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	0	0.21	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	0.49	0.90	0.50	0	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	12	11	13	12	13	9.15	12	8.61	5.97	5.27	4.12	3.77	2.91	1.92	2.39	1.81	–	–
Long-Term Debt	35	34	33	0	–	–	–	0.14	2.46	2.69	2.93	–	–	–	–	–	–	–
Long-Term Leases	4.05	4.48	4.90	0.47	0	0.13	0.24	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	4.46	4.82	5.24	0.69	0.12	0.26	0.34	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	0	0.37	0.56	0.56	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.35	0.26	0.20	0.18	0.17	0.17	0.11	0	0.10	–	–	–	–	–	–	–	–	–
Total Liabilities	52	51	52	14	15	10	13	8.75	8.96	8.89	8.04	20	12	5.29	6.12	6.02	–	–
Total Debt	35	34	33	0	–	–	–	0.14	2.69	2.93	3.17	–	–	–	–	–	–	–
Preferred Stock	0	0	0	0	0	–	–	–	0	0.00	0.00	–	2.26	0	0	0	–	–
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	–	–
Additional Paid-In Capital	104	92	81	73	66	61	57	53	50	50	43	29	29	26	25	25	–	–
Retained Earnings	-89	-78	-54	-36	-13	2.62	15	34	-28	-23	-19	-28	-9.63	-2.64	-3.26	-3.37	–	–
Comprehensive Income & Other	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–
Shareholders' Equity	15	14	27	38	54	64	71	87	22	26	23	1.50	19	23	22	22	21	20
Noncontrolling Interest	0.29	0.13	0.22	0.21	0.31	0.14	0	–	–	–	–	–	–	–	–	–	–	–
Total Equity	15	14	27	38	54	64	71	87	22	26	23	1.50	19	23	22	22	21	20
Total Liabilities & Equity	67	65	79	52	69	74	85	96	31	35	31	25	33	28	28	28	–	–
Shares Outstanding(shares)	42	38	35	35	34	34	34	34	33	31	27	18	18	18	18	17,563	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 63.5%
Operating margin: -6.1%
Net margin: -14.8%
Return on equity, FY2025: -78.0%

Financial strength

Current ratio: 5.68
Debt to equity: 3.31
Debt to assets: 57.8%
Cash to current liabilities: 295.2%

Valuation

P/E ratio: –
Price to sales: 1.82
Price to book: 9.95
Dividend yield: –